News

After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...
This vaccine did previously have emergency approval by the FDA for use but can now be marketed in the U.S. for use, the ...
The FDA has approved the Novavax COVID-19 vaccine, called Nuvaxovid, mainly for adults 65 or older, but people ages 12 to 64 ...
A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make ...
The agency narrowed who can get the shot and added new study requirements that could cost the company tens of millions.
The U.S. Food and Drug Administration approved Novavax's COVID-19 vaccine with age restrictions after a six-week delay.
Italian tyre maker Pirelli is in a risky situation after its Chinese leading shareholder Sinochem rejected a proposal by the ...